Oz Medicann Group Announces Groundbreaking AI Innovation "Ask Sam" to Revolutionize Healthcare

Oz Medicann Group Announces Groundbreaking AI Innovation "Ask Sam" to Revolutionize Healthcare

Sydney, Australia – May 18, 2024 – Oz Medicann Group, a leader in cannabinoid medicine and biotech innovation, is thrilled to announce the launch of "Ask Sam," a revolutionary AI-powered bot designed to transform patient care and streamline medical operations. This cutting-edge technology represents a significant leap forward in personalised healthcare, promising to enhance the efficiency and effectiveness of medical practices across Australia New Zealand and beyond.

Revolutionizing Patient Care with AI

Ask Sam is an advanced AI bot that integrates seamlessly into medical environments, offering a range of groundbreaking features designed to support healthcare professionals and improve patient outcomes. With its ability to provide personalized health advice, manage appointments, and handle patient records, Ask Sam is set to become an indispensable tool for medical practitioners.

Key Features and Benefits

• Personalized Care: Ask Sam delivers tailored health advice and reminders based on individual patient data, ensuring that each patient receives the best possible care.
• 24/7 Availability: Offering round-the-clock support for patient inquiries, Ask Sam reduces wait times and improves patient satisfaction by providing instant responses and information.
• Operational Efficiency: Automating tasks such as appointment scheduling, reminders, and follow-ups, Ask Sam frees up valuable time for healthcare professionals to focus on critical patient care.
• Enhanced Medical Support: Ask Sam assists in preliminary diagnosis by analyzing patient-reported symptoms and providing potential causes, as well as helping patients adhere to their medication schedules.
• Educational Resource: Ask Sam serves as a comprehensive health information resource, delivering accurate, up-to-date medical information to both patients and healthcare providers.

A New Era in Healthcare

"We are incredibly excited to introduce Ask Sam to the market," said John Mc Kenzie Leith, CEO of Oz Medicann Group. "This AI innovation is set to revolutionize how healthcare is delivered, making it more efficient, personalized, and accessible. With Ask Sam, we are taking a significant step towards the future of medicine, where technology and human expertise come together to provide the best possible care."

Join Us in the Future of Healthcare

Oz Medicann Group invites healthcare practitioners and stakeholders to experience the transformative power of Ask Sam. As we continue to push the boundaries of what is possible in medical technology, Ask Sam stands at the forefront of our commitment to innovation and excellence.

About Oz Medicann Group

Founded in 2017 by John Mc Kenzie Leith, Oz Medicann Group is an Australian biotech company specializing in drug development and product innovation around cannabinoid medicine. With a focus on personalized, evidence-based medicine backed by science, Oz Medicann Group is dedicated to improving patient outcomes through cutting-edge research and development.

For more information about Ask Sam and to schedule a demonstration, please contact:

Media Contact:
Rohit Bhuta CEO, Oz Medicann
Group Mobile: 0406 169 146
Email: rohitb@ozmedicann.com
Website: OMGpharma.com.au